In both approaches, the tested molecules were secreted to diffuse through the tumor and were devoid of any moiety that increased circulating half-life (such as Fc or serum albumin-binding domains), minimizing their concentrations outside the tumor and any related off-tumor effects. This evidence concerns the gene ALB and neoplasm.